FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for treating patients with rhinosinusitis with recurrent course of disease. That is ensured by conventional therapy of rhinosinusitis. Before beginning of treatment in patient's blood serum level of substance P. In case of substance P value of 100 pg/mL and less in therapeutic course from first day during 3-5 days involve preparation solution, which is introduced orally in dose of 10 mg 1 time a day.
EFFECT: invention enables reducing the length of treating patient for 4-6 days.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2564006C1 |
| METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
| METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF ACUTE RHINOSINUSITIS | 2016 |
|
RU2617044C1 |
| METHOD FOR EVALUATING EFFICACY OF DRUG-INDUCED THERAPY OF POLYPOUS RHINOSINUSITIS | 2010 |
|
RU2428695C1 |
| METHOD FOR DETERMINING PREVENTIVE APPROACH WITH USE OF GLUCOCORTICOSTEROIDS TO PATIENTS WITH POLYPOUS RHINOSINUSITIS | 2012 |
|
RU2479844C1 |
| METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
| PREDICTION METHOD OF POLYPOUS RHINOSINUSITIS RELAPSE RISK FOR PREVENTIVE THERAPY INDICATIONS | 2007 |
|
RU2338205C1 |
| METHOD FOR TREATMENT OF OLFACTORY DYSFUNCTION IN PATIENTS WITH ACUTE RHINOSINUSITIS | 2017 |
|
RU2638688C1 |
